Back in 2018 the Trump Administration (DOJ) approved the very surgeries his campaign now implies it was a Harris idea. A very interesting fact:
In a surprising twist on the Trump administration’s stance toward LGBTQ+ rights, reports reveal that officials in 2018 greenlit gender-affirming surgeries for transgender inmates in federal custody. This decision allowed the Bureau of Prisons (BOP) to provide gender-affirming care, including surgeries, under specific medical guidelines, despite the administration’s general stance against expanding LGBTQ+ protections elsewhere in government policy.
The policy shift reportedly arose following legal challenges and advocacy pressure. Organizations like Lambda Legal had pressed for better healthcare access for incarcerated transgender individuals, highlighting cases where the lack of such care exacerbated mental health struggles among inmates. By 2018, BOP guidelines mandated healthcare support for gender dysphoria, including gender-affirming procedures where deemed medically necessary, following increased scrutiny on prison conditions and the rights of transgender individuals.
This policy approach during the Trump years presents a complex record of selective support within federal guidelines, contrasting with the administration’s other restrictive actions against LGBTQ+ protections, such as the ban on transgender individuals serving openly in the military. As LGBTQ+ rights remain a polarizing topic in the U.S., this historical decision underscores the tensions and variability within federal policy on transgender healthcare in secure settings.
Trump Administration Approved Gender-Affirming Surgeries for Federal Prisoners in 2018: Policy Sparks Debate Over LGBTQ+ Rights Record
In a surprising twist on the Trump administration’s stance toward LGBTQ+ rights, reports reveal that officials in 2018 greenlit gender-affirming surgeries for transgender inmates in federal custody. This decision allowed the Bureau of Prisons (BOP) to provide gender-affirming care, including surgeries, under specific medical guidelines, despite the administration’s general stance against expanding LGBTQ+ protections elsewhere in government policy.
The policy shift reportedly arose following legal challenges and advocacy pressure. Organizations like Lambda Legal had pressed for better healthcare access for incarcerated transgender individuals, highlighting cases where the lack of such care exacerbated mental health struggles among inmates. By 2018, BOP guidelines mandated healthcare support for gender dysphoria, including gender-affirming procedures where deemed medically necessary, following increased scrutiny on prison conditions and the rights of transgender individuals.
This policy approach during the Trump years presents a complex record of selective support within federal guidelines, contrasting with the administration’s other restrictive actions against LGBTQ+ protections, such as the ban on transgender individuals serving openly in the military. As LGBTQ+ rights remain a polarizing topic in the U.S., this historical decision underscores the tensions and variability within federal policy on transgender healthcare in secure settings.
